Targeted Genetics is a leader in the discovery and development of molecular medicines to prevent or treat acquired, inherited and infectious diseases that have significant unmet medical need. For more than a decade the Company has been at the forefront of innovation in the development of multiple gene delivery systems. As a result, Targeted Genetics has significant expertise in the preclinical development, clinical and regulatory affairs and... More >>

Recent News

More News >>

Date Title   06/22/09 Targeted Genetics Announces Continued Clinical Study at University College London/Moorfields Eye Hospital for a Gene Therapeutic to Treat Leber's Congenital Amaurosis and Provides Business Update 05/14/09 Targeted Genetics Corporation Receives Extension of Nasdaq Compliance Deadline 05/07/09 Targeted Genetics Corporation Reports First Quarter 2009 Financial Results 04/14/09 Targeted Genetics Corporation Receives Nasdaq Delisting Notice

Upcoming Events

More Events >>

There are currently no events scheduled.

Featured Report

Targeted Genetics 2006 Online Annual Report

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Targeted Genetics posts new information to the site. Just enter your e-mail address and click Submit.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.